Skip to content
OpenCapital
Get started

Coya Therapeutics, Inc. COYA Q4 2024 Annual earnings

Reported March 18, 2025 · Before market open

Revenue$2.0KMiss by $98.0K
EPS-$0.18Beat by $0.08
Revenue estimate$100.0K
EPS estimate-$0.26

Next report

Aug 11, 2026 (In 2 weeks)
Revenue estimate$130.0K
EPS estimate-$0.36

Versus estimates

Revenue

Q1 2026$300.0KBeat by $150.0KQ4 2025$4.0MBeat by $1.8MQ3 2025$3.6MBeat by $1.6MQ2 2025$163.6KMiss by $619.7KQ1 2025$257.9KMiss by $2.4M
Q4 2024$2.0KMiss by $98.0K

Diluted EPS

Q1 2026-$0.32Beat by $0.07Q4 2025-$0.34Miss by $0.07Q3 2025-$0.10Miss by $0.12Q2 2025-$0.36Miss by $0.14Q1 2025-$0.44In line
Q4 2024-$0.18Beat by $0.08

Ask the moment Coya Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Coya Therapeutics, Inc. report Q4 2024 earnings?
Coya Therapeutics, Inc. (COYA) reported Q4 2024 earnings on March 18, 2025 before market open.
What were Coya Therapeutics, Inc.'s Q4 2024 revenue and EPS?
Coya Therapeutics, Inc. reported revenue of $2.0K and eps of $-0.18 for Q4 2024.
Did Coya Therapeutics, Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $100.0K by $98.0K. EPS beat the consensus estimate of $-0.26 by $0.08.
Where can I find Coya Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-040782) directly on SEC EDGAR. The filing index links above go to sec.gov.